Physician profile
Paul Levy
NPI 1699779686
$1,328.82
in general payments reported to CMS, 2019-2025
15 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $213 · 2021: $561 · 2022: $187 · 2023: $22.50 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $462.27 | 2020-2022 | |
| Medtronic Vascular, INC. | $140.92 | 2019-2020 | |
| Chiesi USA, INC. | $109.48 | 2021 | |
| Endologix LLC | $103.53 | 2020-2021 | |
| Intuitive Surgical, INC. | $103.09 | 2025 | |
| Penumbra, INC. | $90.61 | 2019 | |
| Haemonetics Corporation | $67.96 | 2021 | |
| Medtronic, INC. | $62.13 | 2022 | |
| Atricure, INC. | $60.00 | 2019 | |
| Silk Road Medical, INC. | $27.56 | 2022 | |
| Cordis US Corp. | $23.32 | 2022 | |
| Innovation Technologies INC | $22.50 | 2023 | Irrisept |
| Livanova USA, INC. | $22.06 | 2020 | |
| Edwards Lifesciences Corporation | $20.24 | 2025 | |
| Janssen Pharmaceuticals, INC | $13.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.